Schizophrenia is one of the more complex mental disorders, typically requiring more than short or outpatient therapy. In most individuals, the disorder is characterized by ongoing psychotic symptoms—delusions, hallucinations, or disorganized speech—coexisting with negative symptoms like social withdrawal or loss of motivation.1 These tend to interfere with school, work, and relationships, and typically affect family members too.
At A Mission For Michael (AMFM), we know that schizophrenia recovery cannot happen overnight. That’s why we provide long-term residential treatment programs in California, Virginia, and Washington State. We don’t just want to mask symptoms – we want to empower every client to build stability, learn new coping skills, and lay the foundation for long-term health. Under the coordination of antipsychotic medication, cognitive behavior therapy (CBT), holistic therapies, and highly structured care in the community, AMFM offers a higher level of care than outpatient facilities.
A residential treatment program is an in-residence treatment program designed for persons with mental illness in need of more than weekly treatment or a partial hospitalization program (PHP). In a residential program, clients are given access 24/7 to clinicians, nurses, and specially trained staff to treat mental illness.2
While outpatient treatment allows a person to remain at home and yet be treated, inpatient residential care creates an organized environment in which recovery can occur with fewer outside distractions or stimulus. For the schizophrenic, this organization creates an environment that allows concentration on recovery, medication, and social skills acquisition.
We accept most major insurance providers and can check your coverage levels for you.
If we are not an appropriate provider for care, we will assist in finding a care provider that can help.
Short-term inpatient stays or short-term care will calm a psychotic episode but rarely provide enough time for complete recovery. Schizophrenia is a serious mental illness that often requires long-term residential treatment that will last for months.3
Long-term treatment allows:
Studies show that patients who complete residential schizophrenia treatment programs successfully are more likely to stay engaged in mental health care and less prone to relapse than those receiving only outpatient treatment.4
Every AMFM residential schizophrenia treatment facility adheres to the same philosophy: treatment must be compassionate, individualized, and evidence-based. Here’s what to expect:
Patients begin with a free, confidential assessment to determine needs. Our team then creates an individualized treatment plan tailored to the patient.
AMFM uses life skills training and wellness activities to help clients be successful in the world outside. These may include:
Residents live in supportive housing with patterns of daily life. Activities balance individual therapy, groups, recreation, and quiet time for contemplation. The pattern brings independence as well as accountability.
Each AMFM center offers the same degree of high-quality care, with special touches:
In all states, AMFM combines mental health treatment, residential living, and community-based healing to improve quality of life.
"*" indicates required fields
Complete the form to receive a prompt call back from a member of our experienced and compassionate admissions staff. All communication is 100% confidential.
Both inpatient treatment and outpatient care are valuable, but for schizophrenia, residential treatment centers often provide the best chance for long-term stability. Outpatient therapy may help manage mild mental health conditions, but for ongoing schizophrenia treatment, long-term programs with 24/7 support offer more lasting results.
Studies show residential program clients are nearly three times as likely to complete care as outpatient clients.6 The gap explains why residential treatment is so powerful for individuals with schizophrenia.
Schizophrenia doesn’t only affect the individual—loved ones and family members are too. AMFM residential treatment programs include:
The long-term goals of residential treatment for schizophrenia are:
With proper care, most return to school, work, or other productive endeavors, with a boost in self-esteem and overall stability.
Complete the form to receive a prompt call back from a member of our experienced and compassionate admissions staff. All communication is 100% confidential.
"*" indicates required fields
Delaying treatment for schizophrenia can make it worse. What starts as nightmares or paranoia can turn into voices, intense flashbacks, and social isolation. With early treatment, however, people are able to stabilize, reconnect with others, and build healthier habits. Families become more comfortable as well when they sense their concerns are being heard.
At AMFM, we prioritize early treatment, screening, and diagnosis. In CBT, antipsychotic medication, or trauma treatments such as EMDR, we aim to offer evidence-based treatments tailored to the unique needs of each individual.
It’s intimidating not knowing where to begin when seeking the optimal residential treatment center for schizophrenia. With so many treatment programs to compare, insurance to navigate, and whether or not a loved one will feel comfortable, the task can be overwhelming. But you are not alone. At AMFM, we take pride in making the first step as easy as possible. We provide free consultations where you can share your concerns, insurance verification information, and in the rare case that for some reason we are not a good fit, we will refer you to another qualified provider who can help.
Call 844-699-3628 today and talk to our admissions team. Together, we can create a treatment plan that promotes recovery and long-term stability. With the right program, caring clinicians, and supportive environment, healing is not just a possibility—it’s a reality.
American Psychiatric Association. What Is Schizophrenia? Accessed September 3, 2025. https://www.psychiatry.org/patients-families/schizophrenia/what-is-schizophrenia.
National Institute of Mental Health (NIMH). Schizophrenia. Accessed September 3, 2025. https://www.nimh.nih.gov/health/topics/schizophrenia.
Carpenter, William T., and Rajiv Tandon. “Diagnosis and Classification of Schizophrenia.” Psychiatric Clinics of North America 36, no. 1 (2013): 1–18. https://doi.org/10.1016/j.psc.2012.12.002.
Saha, Sukanta, et al. “A Systematic Review of the Prevalence of Schizophrenia.” PLoS Medicine 2, no. 5 (2005): e141. https://doi.org/10.1371/journal.pmed.0020141.
Leucht, Stefan, et al. “Second-Generation vs First-Generation Antipsychotic Drugs for Schizophrenia: A Meta-analysis.” The Lancet 373, no. 9657 (2009): 31–41. https://doi.org/10.1016/S0140-6736(08)61764-X.
McHugh, R. Kathryn, et al. “Comparative Effectiveness of Residential vs. Outpatient Treatment for Substance Use Disorders: A Meta-Analysis.” Journal of Nervous and Mental Disease 208, no. 6 (2020): 433–439. https://doi.org/10.1097/NMD.0000000000001151.
Hor, Kahyee, and Martin Taylor. “Suicide and Schizophrenia: A Systematic Review of Rates and Risk Factors.” Journal of Psychopharmacology 24, no. 4_suppl (2010): 81–90. https://doi.org/10.1177/1359786810385490.
